ACS Applied Materials & Interfaces· 2026Q1
Dissolving Microneedles Loaded with Lipid Nanoparticles for Co-Delivery of siTNF-α and Dexamethasone as a Dual-Action Therapy for Psoriasis
- 0citations
- Q1SCImago
- 2026year
Short summary
A hyaluronic acid dissolving microneedle platform co-delivers siTNF-α and dexamethasone encapsulated within novel lipid nanoparticles (LNPs) for enhanced psoriasis treatment, significantly reducing disease severity in a mouse model.
AI-generated from the title and abstract; the full text is not read.
TakeawaysIn the app
Key pointsIn the app
Ask the paperIn the app
The rest is in the Pofolia app
Takeaways, key points and questions to the paper; new summaries every day for your field. Free.
Sign in on the web to openPharmaceutical SciencePharmacology, Toxicology and Pharmaceutics